Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Qatar - Delayed Quote QAR

Qatari German Company for Medical Devices (Q.P.S.C.) (QGMD.QA)

1.3460
-0.0130
(-0.96%)
At close: May 1 at 1:14:27 PM GMT+3
Loading Chart for QGMD.QA
  • Previous Close 1.3590
  • Open 1.3460
  • Bid 1.3460 x --
  • Ask 1.3480 x --
  • Day's Range 1.3400 - 1.3570
  • 52 Week Range 1.2030 - 1.9950
  • Volume 1,963,640
  • Avg. Volume 5,519,900
  • Market Cap (intraday) 156.965M
  • Beta (5Y Monthly) 2.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 8, 2009
  • 1y Target Est --

Qatari German Company for Medical Devices (Q.P.S.C.) manufactures and sells single use disposable syringes in Qatar and internationally. It offers Q JectUltra, an insulin syringe serving as a tool in diabetic care; Q Flow for infusion therapy; Q Need, a single use hypodermic needle; Q Ject, a single use syringe for the curative medications; and Q Safe, a re-use prevention syringe. The company also trades in medical consumables, equipment, tools and supplies, and furniture. In addition, it provides healthcare training. The company was incorporated in 2000 and is headquartered in Doha, Qatar.

www.qgmd.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: QGMD.QA

View More

Performance Overview: QGMD.QA

Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

QGMD.QA
2.25%
MSCI WORLD (^990100-USD-STRD)
1.38%

1-Year Return

QGMD.QA
3.17%
MSCI WORLD (^990100-USD-STRD)
10.96%

3-Year Return

QGMD.QA
38.82%
MSCI WORLD (^990100-USD-STRD)
31.19%

5-Year Return

QGMD.QA
46.30%
MSCI WORLD (^990100-USD-STRD)
78.65%

Compare To: QGMD.QA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: QGMD.QA

View More

Valuation Measures

Annual
As of 5/1/2025
  • Market Cap

    155.46M

  • Enterprise Value

    306.85M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.57

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    30.73

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.83%

  • Return on Equity (ttm)

    -3,823.18%

  • Revenue (ttm)

    9.98M

  • Net Income Avi to Common (ttm)

    -68.49M

  • Diluted EPS (ttm)

    -0.5900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    524.02k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    14.87M

Research Analysis: QGMD.QA

View More

Company Insights: QGMD.QA

Research Reports: QGMD.QA

View More

People Also Watch